CG001419

· Cullgen Australia Pty Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CG001419, covering 2026-02-06 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects [Phase 1]